Skip to content

The Effect of Women's Heart Health Awareness Program

The Effect of a Heart Health Awareness Program on Women's Knowledge, Attitudes, and Practice Toward Cardiovascular Disease and Health Literacy: A Single-Blind Cluster Randomized Controlled Trial

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07502911
Enrollment
207
Registered
2026-03-31
Start date
2026-04-06
Completion date
2026-04-20
Last updated
2026-03-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Health, Cardiovascular Risk Factors, Health Literacy

Keywords

Cardiovascular diseases, women's health, health literacy

Brief summary

The aim of this study is to examine the effect of a gender-specific heart health protection awareness program, incorporating video-supported reminder messages, on knowledge, attitudes, practices (KAP) regarding cardiovascular diseases and health literacy among adult women aged 20 to 64 with no prior diagnosis of cardiovascular disease. The centers where the study is conducted will be divided into intervention (n=4) and control (n=5) groups using cluster randomization. While the intervention group receives a heart health awareness program consisting of three sessions in total, including education, risk factor screening, and individual counseling over a period of three weeks, the control group will receive standard of care. Data will be collected at the beginning of the first session and after the completion of the final session.

Interventions

BEHAVIORALHeart Health Awareness Program

Intervention group participants will receive a 3-week program focused on cardiovascular diseases prevention, consisting of 45-minute weekly sessions. The first two sessions are educational sessions involving visual presentations, Q\&A, and discussions, with informative brochures provided. To reinforce learning, six reminder video messages will be sent via WhatsApp every two days post-educational sessions. The final session includes a CVD risk screening (height, weight, BMI, waist circumference, blood pressure, and blood glucose) followed by brief individual counseling. Interventions will be conducted simultaneously across all sites by specially trained nurses. Pre-test measurements will be taken before the intervention, and post-tests will be administered upon completion of the final session.

Sponsors

Lokman Hekim University
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Masking description

The study is designed as single-blind at the participant level. The data collection process will be conducted by independent individuals outside of the research team who are unaware of the participants' group assignments. However, the Principal Investigator, who will analyze and evaluate the data, is not blinded as they are aware of the group assignments.

Intervention model description

This is a cluster randomized study. Randomization was performed at the center level rather than at the individual level.

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 64 Years
Healthy volunteers
Yes

Inclusion criteria

* Being female, * Aged between 20 and 64 years (inclusive), * Being literate, * Regularly attending any course at the Family Center, * Active user of the WhatsApp application.

Exclusion criteria

* Being an immigrant with a Turkish language barrier (unable to communicate in Turkish), * Being pregnant, * Being in the postpartum period, * Having a prior diagnosis of any cardiovascular disease, * Having a prior diagnosis of any type of cancer.

Design outcomes

Primary

MeasureTime frameDescription
Change in knowledge sub-dimension scores of the Cardiovascular Disease KAP Scale from baseline to post-intervention.Baseline (Week 0) and at the end of the 3-week intervention periodThe knowledge sub-dimension of the scale consists of 12 items designed to assess individuals' knowledge levels regarding cardiovascular disease risk factors and symptoms. Each item is scored as 0, 1, or 2, with total sub-dimension scores ranging from a minimum of 0 to a maximum of 24.
Change in attitude sub-dimension scores of the Cardiovascular Disease KAP Scale from baseline to post-interventionBaseline (Week 0) and at the end of the 3-week intervention periodThe attitude sub-dimension of the scale consists of 10 items designed to assess individuals' attitudes toward cardiovascular diseases. It utilizes a 5-point Likert-type scale, with total scores ranging from a minimum of 10 to a maximum of 50.
Change in physical activity behaviors sub-dimension scores of the Cardiovascular Disease KAP Scale from baseline to post-interventionBaseline (Week 0) and at the end of the 3-week intervention periodThe physical activity practices sub-dimension of the scale consists of two items assessing individuals' practices regarding cardiovascular disease risk factors. These items are scored using a 3-point rating scale (0-2).
Change in diet and smoking behavior behaviors sub-dimension scores of the Cardiovascular Disease KAP Scale from baseline to post-interventionBaseline (Week 0) and at the end of the 3-week intervention periodThe diet and smoking practices sub-dimension of the scale consists of five items assessing individuals' practices regarding cardiovascular disease risk factors. These items are scored using a 3-point rating scale (0-2).

Secondary

MeasureTime frameDescription
Change in Health Literacy Scale-Short Form scores from baseline to post-interventionBaseline (Week 0) and at the end of the 3-week intervention periodThe scale consists of 12 items and is scored using a 4-point Likert-type scale (ranging from 1 to 4). The index value is calculated using the formula Index = (Mean - 1) X 50 / 3, resulting in a score between 0 and 50. A higher score represents better health literacy.

Countries

Turkey (Türkiye)

Contacts

CONTACTNurbanu Odacı
nur_banu_odaci@hotmail.com+904448548

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 1, 2026